Syncor acquires Trinidad and Tobago MRI center
Syncor Overseas, a subsidiary of nuclear pharmaceutical and medical imaging company Syncor, has acquired MRI Trinidad and Tobago, an MRI center in Port of Spain, Trinidad and Tobago. Syncor acquired the center from Magnetic Resonance Imaging of Trinidad
Syncor Overseas, a subsidiary of nuclear pharmaceutical and medical imaging company Syncor, has acquired MRI Trinidad and Tobago, an MRI center in Port of Spain, Trinidad and Tobago.
Syncor acquired the center from Magnetic Resonance Imaging of Trinidad and Tobago Ltd., said Mike Mikity, Syncors senior vice president and chief financial officer. The Woodland Hills, CA-based company already operates imaging centers in Puerto Rico, Mexico, and Colombia.
MRI Trinidad and Tobago generated $1 million in 1999 and Syncor expects the new center to make money for the company this year, Mikity said. Another Syncor subsidiary, Comprehensive Medical Imaging, operates 42 domestic and seven international imaging centers.
Correction:An article in SCAN 4/12/00 stated that a Syncor subsidiary operates 43 PET centers in Florida, Arizona, and Southern California. It should have said Comprehensive Medical Imaging operates 43 imaging centers in those states. Syncor plans to open its first PET center sometime in the third quarter 2000 in Rancho Mirage, CA.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
